Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 440-449, 2003; 10.1373/49.3.440
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Legros, F. J.
Right arrow Articles by Henry, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Legros, F. J.
Right arrow Articles by Henry, J.-P.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2003;49:440-449.)
© 2003 American Association for Clinical Chemistry, Inc.

Use of Capillary Zone Electrophoresis for Differentiating Excessive from Moderate Alcohol Consumption

Franz J. Legros1a, Vincent Nuyens1, Michel Baudoux2, Karim Zouaoui Boudjeltia1, Jean-Luc Ruelle3, Jacques Colicis3, Francis Cantraine4 and Jean-Pol Henry2

1 Laboratory of Experimental Medicine and
2 Department of Gastroenterology, Université Libre de Bruxelles and CHU André Vésale, 706 route de Gozée, 6110 Montigny-le-Tilleul, Belgium.

3 Laboratory of Clinical Chemistry, CHU André Vésale, 706 route de Gozée, 6110 Montigny-le-Tilleul, Belgium.

4 Department of Computer Science, Université Libre de Bruxelles, School of Medicine, 808 route de Lennik, 1070 Brussels, Belgium.

aAuthor for correspondence. Fax 32-71-92-47-10; e-mail franz.legros{at}chu-charleroi.be.

Background: The poorly sialylated transferrin isoforms in serum were analyzed by capillary zone electrophoresis (CZE) to differentiate moderate from heavy alcohol consumption.

Methods: We enrolled 614 volunteers, classified after interviews, self-reported drinking habits, and AUDIT scores as alcohol abusers (consuming >50 g/day ethanol for the previous 3 months or longer; n = 413) or moderate drinkers (<30 g/day ethanol; n = 201). Serum transferrin isoforms were separated at 28 kV and monitored at 214 nm on a P/ACE 5500 CZE with use of fused-silica capillaries and the related CEofix CDT reagent set. Immunosubtraction by anti-human transferrin and electrophoretic migration times identified the isoforms. Previous markers of alcohol abuse and an assay combining anion-exchange minicolumn chromatography with immunoturbidimetry (%CDT) were included in the study. Sensitivities and specificities were compared by ROC analysis.

Results: The asialylated isoform was missing in 95% of moderate drinkers but present in 92% of alcohol misusers. Disialotransferrin had a specificity and sensitivity of 0.75 at a cutoff of 0.7% of total transferrin, whereas the sum (asialo- + disialotransferrin) at a threshold of 1.2% had a sensitivity of 0.73 and a specificity of 0.92. Trisialotransferrin values did not distinguish between the two populations. Sensitivities and specificities of %CDT averaged 0.77 and 0.74, respectively, at a 2.6% cutoff; 0.67 and 0.83 at 2.8%; and 0.63 and 0.90 at 3%. CDT data were more sensitive and specific for males. Conventional biomarkers appeared less discriminating.

Conclusions: Asialotransferrin detected by CZE in sera of alcohol abusers offers the highest discrimination between excessive and moderate drinking.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
B. M.R. Appenzeller and R. Wennig
Altered Distribution of Transferrin Isoforms According to Serum Storage Conditions
Clin. Chem., November 1, 2005; 51(11): 2159 - 2162.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
J.-B. Daeppen, F. Anex, B. Favrat, A. Bissery, J. Leutwyler, R. Gammeter, P. Mangin, and M. Augsburger
Carbohydrate-Deficient Transferrin Measured by Capillary Zone Electrophoresis and by Turbidimetric Immunoassay for Identification of Young Heavy Drinkers
Clin. Chem., June 1, 2005; 51(6): 1046 - 1048.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Schwan, L. Malet, M.N. Loiseaux, and P.M. Llorca
Which Types of Alcohol-Use Disorder Will Asialotransferrin Detect?
Clin. Chem., April 1, 2004; 50(4): 782 - 782.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
H. A. Carchon, R. Chevigne, J.-B. Falmagne, and J. Jaeken
Diagnosis of Congenital Disorders of Glycosylation by Capillary Zone Electrophoresis of Serum Transferrin
Clin. Chem., January 1, 2004; 50(1): 101 - 111.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Ramdani, V. Nuyens, T. Codden, G. Perpete, J. Colicis, A. Lenaerts, J.-P. Henry, and F. J. Legros
Analyte Comigrating with Trisialotransferrin during Capillary Zone Electrophoresis of Sera from Patients with Cancer
Clin. Chem., November 1, 2003; 49(11): 1854 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Helander, A. Husa, and J.-O. Jeppsson
Improved HPLC Method for Carbohydrate-deficient Transferrin in Serum
Clin. Chem., November 1, 2003; 49(11): 1881 - 1890.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
P. Anttila, K. Jarvi, J. Latvala, J. E. Blake, and O. Niemela
DIAGNOSTIC CHARACTERISTICS OF DIFFERENT CARBOHYDRATE-DEFICIENT TRANSFERRIN METHODS IN THE DETECTION OF PROBLEM DRINKING: EFFECTS OF LIVER DISEASE AND ALCOHOL CONSUMPTION
Alcohol Alcohol., September 1, 2003; 38(5): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. Arndt
Asialotransferrin--An Alternative to Carbohydrate-deficient Transferrin?
Clin. Chem., June 1, 2003; 49(6): 1022 - 1023.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.